Classification of Glioblastoma Multiforme in Adults by Molecular Genetics
Authors:
- Joanna CapparellaJCJoanna Capparella
- Alice BrownABAlice Brown
- 1 March 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 9 (2) , 82-90
Abstract
Recent advances in cytogenetic and molecular methodologies have elucidated certain principal characteristics of oncogenesis in glioblastoma multiforme. The earliest clues implicate gene sequence alterations, such as gene amplification and numerical gain or loss of function in specific chromosomes. Genetic classification and expression patterns have thus been constructed, conferring the likelihood of two types of glioblastoma, primary (de novo) as opposed to secondary (evolving from a pre-existing low-grade glioma). The former group of tumors exhibits more frequent occurrences of EGFR gene amplification, whereas the latter group relies strongly on TP53gene inactivation. Many other tumor suppressor genes and oncogenes have been discovered. Most gene alterations induce cell cycle dysfunction on a complex molecular level. Further insight into tumor genesis by means of genomic assays may aid in predicting the clinical behavior of glioblastoma and in providing individualized potential targets for therapeutic agents.Keywords
This publication has 51 references indexed in Scilit:
- Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour‐associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhoodNeuropathology and Applied Neurobiology, 2002
- Loss of Heterozygosity on Chromosome 19 in Secondary GlioblastomasJournal of Neuropathology & Experimental Neurology, 2000
- Molecular pathogenesis of malignant gliomasCurrent Opinion in Oncology, 1999
- The molecular genetics of central nervous system tumorsPathology, 1998
- Genetics of Glioma Progression and the Definition of Primary and Secondary GlioblastomaBrain Pathology, 1997
- Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma MultiformeBrain Pathology, 1997
- Malignant Astrocytomas with Homozygous CDKN2/p16 Gene Deletions Have Higher Ki-67 Proliferation IndicesJournal of Neuropathology & Experimental Neurology, 1996
- A tiger behind many doors: multiple genetic pathways to malignant gliomaTrends in Genetics, 1995
- MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9pHuman Molecular Genetics, 1994
- Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumorsJournal of Neurosurgery, 1994